Recent PRME News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 08:06:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:03:46 PM
- Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/13/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 12:22:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:05:55 PM
- Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 05/10/2024 12:00:00 PM
- Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD) • GlobeNewswire Inc. • 05/08/2024 12:00:00 PM
- Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference • GlobeNewswire Inc. • 05/01/2024 12:00:00 PM
- Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 01:09:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/01/2024 01:04:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:01:39 PM
- Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/01/2024 01:00:00 PM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/28/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:03:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:02:07 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 02/23/2024 02:31:04 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 10:38:59 PM
- Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares • GlobeNewswire Inc. • 02/20/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 11:23:32 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/16/2024 11:17:43 AM
- Prime Medicine Announces Pricing of Upsized Public Offering • GlobeNewswire Inc. • 02/15/2024 04:50:13 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 02/15/2024 02:57:13 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 02/14/2024 10:27:55 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM